Management of Neuromuscular Blocking Agents and Their Antagonism
Clinical Practice Survey on the Management of Neuromuscular Blocking Agents and Their Antagonism During General Anesthesia
Erasme University Hospital
3,000 participants
Apr 17, 2024
OBSERVATIONAL
Conditions
Summary
Neuromuscular blocking agents (NMBA) are commonly used in clinical practice during general anesthesia to facilitate induction, intubation and surgery. Some studies have shown that their use can be deleterious if not codified. Recent recommendations concerning their use and antagonization were published in 2023. Research hypothesis: Using a single-center, retrospective practice study, we aim to analyze whether the 2023 ASA and ESAIC recommendations are being implemented regarding the use of neuromuscular blocking agents.
Eligibility
Inclusion Criteria1
- \- All patients undergoing surgery with use of neuromuscular blocking agents at our institution
Exclusion Criteria1
- \- Incomplete electronic anesthesia record
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Administration of any neuromuscular blocking agent for surgery under general anesthesia
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06238219